In the US, Tricor (fenofibrate systemic) is a member of the drug class fibric acid derivatives and is used to treat Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL and Hypertriglyceridemia.
Ingredient matches for Tricor
Adenosine is reported as an ingredient of Tricor in the following countries:
Fenofibrate is reported as an ingredient of Tricor in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Russian Federation
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.